Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hickman

Showing results (191-200 of 224) with videos related to

Pageof 23
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2018
Correction: Influenza A Virus Negative Strand RNA Is Translated for CD8<sup>+</sup> T Cell ImmunosurveillanceHeather D Hickman, Jacqueline W Mays, James Gibbs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 18, 2018
Influenza A Virus Negative Strand RNA Is Translated for CD8<sup>+</sup> T Cell ImmunosurveillanceHeather D Hickman, Jacqueline W Mays, James Gibbs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 16, 2010
Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responsesScott E Hensley, Damien Zanker, Brian P Dolan, et al.
Cell Reports. Medicine|July 24, 2020
An Agonistic Anti-CD137 Antibody Disrupts Lymphoid Follicle Structure and T-Cell-Dependent Antibody ResponsesJun P Hong, Glennys V Reynoso, Prabhakar S Andhey, et al.
Pilot and Feasibility Studies|March 21, 2026
Mindful self-compassion to reduce stigma among individuals diagnosed with lung cancer (MSC-LC): a pilot study protocol for a parallel-group, randomized controlled trialTimothy J Williamson, Whitney M Brymwitt, Jamie S Ostroff, et al.
Trials|January 6, 2026
Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)M Olugbosi, M Beumont, L Lombard, et al.
Nature Communications|May 29, 2021
A sand fly salivary protein acts as a neutrophil chemoattractantAnderson B Guimaraes-Costa, John P Shannon, Ingrid Waclawiak, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
Outflanking immunodominance to target subdominant broadly neutralizing epitopesDavide Angeletti, Ivan Kosik, Jefferson J S Santos, et al.
Science Immunology|May 30, 2025
An activating <i>Stat1</i> mutant disrupts normal STAT4 innate lymphocyte programs during viral infectionRachael L Philips, Yi-Chu Liao, Colleen M Lau, et al.
ESMO Open|September 9, 2022
Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumorsH Park, G I Shapiro, X Gao, et al.
Pageof 23

Showing results (191-200 of 224) with videos related to

Sort By:
Pageof 23
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2018
Correction: Influenza A Virus Negative Strand RNA Is Translated for CD8<sup>+</sup> T Cell ImmunosurveillanceHeather D Hickman, Jacqueline W Mays, James Gibbs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 18, 2018
Influenza A Virus Negative Strand RNA Is Translated for CD8<sup>+</sup> T Cell ImmunosurveillanceHeather D Hickman, Jacqueline W Mays, James Gibbs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 16, 2010
Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responsesScott E Hensley, Damien Zanker, Brian P Dolan, et al.
Cell Reports. Medicine|July 24, 2020
An Agonistic Anti-CD137 Antibody Disrupts Lymphoid Follicle Structure and T-Cell-Dependent Antibody ResponsesJun P Hong, Glennys V Reynoso, Prabhakar S Andhey, et al.
Pilot and Feasibility Studies|March 21, 2026
Mindful self-compassion to reduce stigma among individuals diagnosed with lung cancer (MSC-LC): a pilot study protocol for a parallel-group, randomized controlled trialTimothy J Williamson, Whitney M Brymwitt, Jamie S Ostroff, et al.
Trials|January 6, 2026
Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)M Olugbosi, M Beumont, L Lombard, et al.
Nature Communications|May 29, 2021
A sand fly salivary protein acts as a neutrophil chemoattractantAnderson B Guimaraes-Costa, John P Shannon, Ingrid Waclawiak, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
Outflanking immunodominance to target subdominant broadly neutralizing epitopesDavide Angeletti, Ivan Kosik, Jefferson J S Santos, et al.
Science Immunology|May 30, 2025
An activating <i>Stat1</i> mutant disrupts normal STAT4 innate lymphocyte programs during viral infectionRachael L Philips, Yi-Chu Liao, Colleen M Lau, et al.
ESMO Open|September 9, 2022
Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumorsH Park, G I Shapiro, X Gao, et al.
Pageof 23